As from April 2013 my Journey in Investing is to create Retirement Income for Life till 85 years old in 2041 for two persons over market cycles of Bull and Bear.

Click to email CW8888 or Email ID : jacobng1@gmail.com



Welcome to Ministry of Wealth!

This blog is authored by an old multi-bagger blue chips stock picker uncle from HDB heartland!

"The market is not your mother. It consists of tough men and women who look for ways to take money away from you instead of pouring milk into your mouth." - Dr. Alexander Elder

"For the things we have to learn before we can do them, we learn by doing them." - Aristotle

It is here where I share with you how I did it! FREE Education in stock market wisdom.

Think Investing as Tug of War - Read more? Click and scroll down



Important Notice and Attention: If you are looking for such ideas; here is the wrong blog to visit.

Value Investing
Dividend/Income Investing
Technical Analysis and Charting
Stock Tips

Sunday, 12 June 2011

Biosensors acquiring the remaining 50% interest in JWMS

Weigao becoming a major shareholder of Biosensors

 
12 June 2011 ‐ Biosensors International Group, Ltd. (“Biosensors”) and Shandong Weigao Group Medical Polymer Company Limited (“Weigao”) announced the restructuring of the shareholding in JW Medical Systems Ltd (“JWMS”) whereby Biosensors acquires the remaining 50% of JWMS from Weigao. After completing this transaction, JWMS will be a wholly-owned subsidiary of Biosensors.

Subject to the obtaining of the required approvals, the purchase consideration (the “Purchase Consideration”) for Weigao shall comprise: (i) a cash payment of S$160,000,000; (ii) the issuance to Weigao of 260,000,000 new ordinary shares of Biosensors, and; (iii) the issuance to Weigao of US$120,043,000 principal amount of 4% convertible notes due 2014 from Biosensors.

After the completion of this transaction, Weigao will be a strategic shareholder of Biosensors and will participate in Biosensors’ development through its membership in Biosensors’ board.

Mr. Yoh-Chie Lu, Chairman of Biosensors said, “Since commercialization of its drug-eluting stents (“DES”) in early 2006, JWMS has become one of the top suppliers of the local DES market in China. This acquisition demonstrates a joint dedication between Biosensors and Weigao to foster stronger relationships as long-term strategic partners. The market for DES continues to grow rapidly in China and obtaining full ownership of JWMS,

Biosensors will instantaneously become a stronger player in this vital market. At the same time, with Weigao as a strategic shareholder of Biosensors and our unique proprietary drug and polymer technologies, we are set to become a major DES supplier in China for many years to come.“

“As one of the largest economy in the world, China presents a fastest growing market for companies with innovative technologies and operational excellence.” Mr. Chen Xue Li, Chairman of Weigao said, “Being a key shareholder of Biosensors, we are committed to make Biosensors the premier medical technology company in China and the global market.”

No comments:

Post a comment

Related Posts with Thumbnails